NCT04223154

Brief Summary

Alcohol Use Disorder (AUD) is prevalent, devastating, and difficult to treat. The intransigence of AUD is readily apparent in the Trauma Unit of Wake Forest University Baptist Hospital, wherein 23% of trauma related admissions are associated with alcohol - higher than the national average of 16%. Of these trauma related admissions, over 70% are estimated to have AUD and 41% will be likely be admitted to the trauma unit again within 5 years. While Dr. Veach (Co-Investigator) and her team in the Department of Surgery have demonstrated that a brief counseling intervention on the inpatient trauma unit can decrease morbidity and recidivism, the rates of AUD and relapse to drinking among these individuals remains very high. With a growing knowledge of the neural circuits that contribute to relapse in AUD, there is an emerging interest in developing a novel, neural-circuit specific therapeutic tool to enhance AUD treatment outcomes. This will be achieved through a double-blind, sham-controlled cohort study in heavy alcohol drinkers with a history of alcohol-related injury. The brain reactivity to alcohol cues (Incentive Salience) and cognitive performance in the presence of an alcoholic beverage cue (Cognitive Control) will be measured immediately before and after participants receive real or sham intermittent theta burst stimulation (iTBS- a potentiating form of transcranial magnetic stimulation (TMS)) to the dorsolateral prefrontal cortex (dlPFC iTBS). The goals of this pilot study are to quantify the acute effect of a single session of real or sham dlPFC iTBS on brain response to alcohol cues (Aim 1) and cognitive flexibility in the presence of an alcohol cue (Aim 2) among risky drinkers (target engagement ).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 7, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 10, 2020

Completed
8 months until next milestone

Study Start

First participant enrolled

August 26, 2020

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 16, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 16, 2021

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

November 10, 2022

Completed
Last Updated

May 19, 2023

Status Verified

September 1, 2022

Enrollment Period

8 months

First QC Date

January 7, 2020

Results QC Date

September 8, 2022

Last Update Submit

May 17, 2023

Conditions

Keywords

Transcranial Magnetic StimulationBrain StimulationNeuroimaging

Outcome Measures

Primary Outcomes (1)

  • Behavioral Outcomes: Change in the k-Value, a Measure of Delay Discounting of Alcohol

    This outcome measure rates the change in k-value, or the delay discounting value of alcohol compared at baseline vs 1 hour after the intervention. Delay discounting is the tendency to place less value on rewards that are delayed in time. K typically falls between 0.0 and 0.5, with smaller values indicating a lack of discounting and a preference for delayed rewards, and higher values indicating stronger discounting and a preference for immediate rewards.

    Baseline to 1 hour after the intervention

Study Arms (2)

Real TBS to the dlPFC

EXPERIMENTAL

One session of real intermittent Theta Burst Stimulation (TBS) will be delivered to the left dorsolateral prefrontal cortex (dlPFC)

Device: Real iTBS to the dlPFC

Sham TBS to the dlPFC

SHAM COMPARATOR

One session of sham Theta Burst Stimulation (TBS) will be delivered to the left dorsolateral prefrontal cortex (dlPFC)

Device: Sham iTBS to the dlPFC

Interventions

This will be delivered with the Magventure Magpro system; 600 pulses with the active sham coil (double blinded using the USB key).

Real TBS to the dlPFC

This will be delivered with the Magventure Magpro system; 600 pulses with the active sham coil (double blinded using the USB key).

Sham TBS to the dlPFC

Eligibility Criteria

Age21 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ages 21-65.
  • Alcohol use disorder identification test score \>7
  • Drink at least 20 standard sized alcohol beverage servings per week

You may not qualify if:

  • Current use of prescription or illicit psychoactive drugs (except marijuana or nicotine) known to decrease seizure threshold by self-report in the last 30 days.
  • Currently meets DSM-V criteria for substance use disorder for a substance other than alcohol, marijuana, or nicotine.
  • Has current suicidal or homicidal ideation.
  • Current breath alcohol concentration \>0.002
  • Not currently at risk for withdrawal, as indicated by CIWA-Ar \>5.
  • History of seizures or seizure disorder(s).
  • Females of childbearing potential who are pregnant (by urine HCG), planning to become pregnant, nursing, or who are not using a reliable form of birth control.
  • Any other violation of MRI/TMS safety measures.
  • Unable to read and understand questionnaires, assessments, and the informed consent.
  • No presence of metal objects in the head/neck.
  • History of traumatic brain injury resulting in hospitalization, loss of consciousness for more than 10 minutes, and/or having ever been informed he/she has an epidural, subdural, or subarachnoid hemorrhage.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wake Forest Baptist Health Sciences

Winston-Salem, North Carolina, 27157, United States

Location

MeSH Terms

Conditions

Alcohol DrinkingAlcoholismAccidental Injuries

Condition Hierarchy (Ancestors)

Drinking BehaviorBehaviorAlcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental DisordersWounds and Injuries

Results Point of Contact

Title
Colleen A. Hanlon, Ph.D.
Organization
Wake Forest University School of medicine

Study Officials

  • Colleen Hanlon, PhD

    Wake Forest University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 7, 2020

First Posted

January 10, 2020

Study Start

August 26, 2020

Primary Completion

April 16, 2021

Study Completion

April 16, 2021

Last Updated

May 19, 2023

Results First Posted

November 10, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

No individual participant data will be shared. All data is de-identified.

Locations